Breaking News
Investing Pro 0
Final hours: unlock premium data with Claim 60% OFF

Dormakaba beats annual sales forecast, aided by price hikes

Published Aug 31, 2023 06:40 Updated Aug 31, 2023 08:51
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: The logo of the Swiss Dormakaba security group is seen at its headquarters in Ruemlang, Switzerland, July 22, 2021. REUTERS/Arnd Wiegmann/File Photo
 
ASSAb
+0.70%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ALLE
+5.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Tristan Veyet and Paolo Laudani

(Reuters) - Dormakaba beat full-year sales and margin forecasts on Thursday, as price increases helped the Swiss security device maker improve its performance in the second half of the fiscal year.

The company, whose products range from entrance systems to safe locks, reported net sales of 2.85 billion Swiss francs ($3.24 billion) for the year through June, up 8.4% organically and ahead of analysts' forecast of 2.82 billion in a company-provided poll.

The shares were up 3.61% in early trading.

The results mirror wider market trends, after Swedish lock maker Assa Abloy and Dublin-based electric security device maker Allegion also reported higher quarterly revenues on solid demand.

Sales were helped by the easing of global supply chain disruptions that allowed locking device makers to get raw materials and key electronic components such as chips on time.

"It is not an entirely return to normal situation," Dormakaba Chief Executive Jim-Heng Lee said about the improved chip supplies in an interview with Reuters.

Regionally, the Americas division saw strongest organic sales growth at 10.5%, while Asia-Pacific was the weakest with 2.2% growth, reflecting a sluggish China recovery.

"Clearly recovery so far (in China) has been below expectations. We have to take internal measures in order to focus on growth opportunities within our Chinese market," Lee said.

For the 2023/24 financial year, Dormakaba expects its profitability to improve from the prior year, helped by pricing and cost management. Organic sales growth should come in line with the mid-term target of 3-5%, it said.

The annual margin on adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) was in line with last year at 13.5%, beating the 13.2% expected by analysts.

The company said it would pay a dividend of 9.50 Swiss francs per share for the year, below the 11.50 francs per share it paid for fiscal 2021/22.

($1 = 0.8783 Swiss francs)

Dormakaba beats annual sales forecast, aided by price hikes
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email